GI/endoscopy company stock report – Jan. 30, 2015

Here is a stock report on five publicly traded GI/endoscopy companies for Jan. 26 to Jan. 30.

Advertisement

•    AbbVie: $61.15 per share (down 3.07 percent)
•    Boston Scientific: $14.88 per share (up 0.2 percent)
•    FUJIFILM Holdings: 3,998 per share (JPY) (up 0.33 percent)
•    Olympus: 4,120 per share (JPY) (down 0.36 percent)
•    Salix Pharmaceuticals: $135.99 per share (up 0.64 percent)

More articles on gastroenterology:
8 gastroenterologist inventors
6 must-reads on GERD diagnosis & treatment
14 statistics on gastroenterologist burnout

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.